The effect of dietary conjugated linoleic acid (CLA) isomers (CLAmix), Na 2
INTRODUCTION
The spleen is an important internal organ found in practically all vertebrate animals and plays a crucial role in regard to red blood cells as well as the immune system (Gilmore, 2006; Perkins, 2007) . It removes old red blood cells, holds a reserve of blood in case of haemorrhagic shock, and also recycles iron. This organ synthesizes antibodies in its white pulp and removes antibody-coated bacteria along with antibody-coated blood cells by way of blood and lymph node circulation. Additionally, the spleen also clears bacteria and is important for proper immune function, especially in fighting bacteria. Other important functions of the spleen include erythropoiesis, storage of red blood cells and other formed elements, as well as production of opsonins, properdin, and tuftsin (Brender et al., 2005; Harold, 2010) . Interestingly, the cells that consumption larger amounts of Se are immune cells, erythrocytes and platelets (Yusuf et al., 2002; Navarro-Alarcon and Cabrera-Vique, 2008; Slavik et al., 2008) . Moreover, Se is needed for the proper functioning of the immune system. On the other hand, a low Se concentration in food is associated with a decrease in immune efficiency as well as poor growth and impairment of animal production (Navarro-Alarcon and Cabrera- Vique, 2008) . Animal investigations have also documented that isomer mixtures of conjugated linoleic acid (CLA) as well as individual cis9trans11CLA (c9t11CLA) and trans10cis12CLA (t10c12CLA) isomers might have a beneficial influence on the immune system (Jørgensen et al., 2010) and possess antiproliferative, antitumour, antiinflammatory and antiatherogenic properties (De La Tore et al., 2006; Naumann et al., 2006) . Solid evidence based on epidemiological studies conducted in the last 50 years shows positive relationships between Se and CLA isomer dietary intake and the effectiveness of immune functions in living organisms (Yu et al., 2002 (Yu et al., , 2008 Park and Pariza, 2007; Navarro-Alarcon and Cabrera-Vique, 2008) . In addition, recent investigations have shown that dietary supplementation with CLA isomers and various Se-sources affected the concentration of fatty acids in the spleen, blood, and other tissues in examined animals (Czauderna et al., 2007a (Czauderna et al., , 2009 (Czauderna et al., , 2010a Jørgensen et al., 2010) . Importantly, long-chain polyunsaturated fatty acids (LPUFA), especially n-3LPUFA, showed a positive influence on the immune system in living organisms. Changes in the concentration of these fatty acids in animal tissues depended on the chemical forms of Se and/or CLA isomers in a diet (Yu et al., 2008) .
Considering the above, we hypothesized that addition of Se (as selenite or organic Se) and CLA isomers to a rat diet affected the level of LPUFA in the spleen and blood of rats. Therefore, the aim of the current study was to investigate the influence of a diet enriched in CLA isomer mixture (CLAmix) and different doses of sodium selenite (SeIV) or selenized yeast (SeY) on the fatty acid profiles in the spleen and blood plasma of rats. Selenized yeast has been shown to be a highly bioavailable source of Se (Rayman, 2004) .
MATERIAL AND METHODS

Animals, housing, diets, sampling and analytical methods
Ten groups of female rats (Wistar, Hsd Brl Han: WIST), 8 weeks of age with an initial body weight of 195.4±0.8 g were housed individually in plastic cages and fed the control and experimental diets as described in detail in our previous publication (Czauderna et al., 2010a) .The rats were housed and handled in accordance with protocols approved by the Local Animal Care and Use Committee (the Agricultural University of Warsaw, Poland). Briefly, after a 7-day preliminary period, for 6 weeks the rats were fed ad libitum the standard Labofeed H diet (Czauderna et al., 2009 ) supplemented with 1.5% CLA mix (Czauderna et al., 2010a) , 0.2 ppm Se as sodium selenite ( L SeIV) or selenized yeast ( L SeY) or 0.5 ppm Se as SeIV ( H SeIV) or SeY ( H SeY). SeIV, SeY and/or CLAmix mixed with a finely powdered standard Labofeed H diet. The rats were killed at the end of the six-week experiment. Spleens were removed, weighed, and frozen, blood samples were collected and processed as described in our previous publication (Niedźwiedzka et al., 2007) .
Lipids in spleen (~25 mg) and blood plasma (100 μl) samples were saponified (Czauderna et al., 2009 ) followed by gentle base-and acid-catalysed methylations of free fatty acids (Czauderna et al., 2007b) . Tissue fatty acids were quantified as methyl esters using capillary gas chromatography with a quadrupole mass selective detector as previously described (Czauderna et al., 2010a) .
Chemicals, chromatographic equipment and statistical analysis
All of the fatty acid standards and reagents, saponification (Czauderna at al., 2009) and methylation (Czauderna et al., 2007b ) methods, as well as chromatographic equipment were as previously described (Czauderna et al., 2010a) .
Results are presented as means of individually analysed samples of fresh spleen and blood plasma. Statistical analyses of the effects of dietary CLA isomer mixture and selenite or selenized yeast (i.e. SeIV or SeY) on the concentration of fatty acids and enzyme indexes were conducted using the non-parametric Mann-Whitney U test for comparing independent experimental groups. Statistical analyses of the interaction between CLAmix and Se (as SeIV or SeY) were performed using twofactorial ANOVA. For statistical analyses the program Statistica ver. 6 (Statistica by StatSoft, 2002) was used.
RESULTS AND DISCUSSION
The effect the experimental diets on the concentration of CLA isomers in the spleen and blood plasma of rats. In the current study, no macroscopic lesions or pathological changes were found in the spleen or any of the other organs of rats fed diets enriched in the CLAmix and/or Se (as L SeY, H SeY, L SeIV or H SeIV). As can be seen from the results (Table 1) , the addition of CLAmix to the diet enriched in SeIV, irrespective of the concentration of extra SeIV, increased the weight of the spleen in comparison with rats fed the diet containing only SeIV or with the control group. On the other hand, the diets enriched in CLAmix or H SeY, or the diet containing CLAmix and SeY (as L SeY or H SeY), decreased spleen weight. In comparison with the control diets, the other experimental diets showed a small and inconsistent influence on the spleen weight.
Supplementing CLAmix to the diet reduced the total concentration of all assayed fatty acids (ΣFA) in the spleen compared with the control (Table 1) . Moreover, the addition of SeIV or SeY to the diet enriched in CLAmix enhanced reduction of the concentration of ΣFA in the spleen. The addition of H SeY to the diet also tended to reduce the concentration of ΣFA. Similarly, the addition of selenate to the rat diet decreased the concentration of ΣFA in the spleen (Niedźwiedzka et al., 2006) . On the other hand, the higher dietary SeIV content stimulated the accumulation of ΣFA in the spleen.
In plasma, the addition of 1.5% CLAmix to the diet stimulated the accumulation of ΣFA, which is in agreement with that of Niedźwiedzka et al. (2006) who reported that diets enriched in 1% or 2% CLAmix also increased the concentration of ΣFA in plasma. Moreover, as can be seen from the present study, the addition of H SeY to the diet, regardless of the presence of CLAmix, stimulated the accumulation of ΣFA in plasma (Table 1) .
The addition of CLAmix to the diet significantly increased (P<0.01) the concentration of c9t11CLA and t10c12CLA in the spleen and blood plasma of SeIV, or L SeY resulted in decreasing in the concentration of CLA isomers in the spleen. Considering above, we suggest that dietary SeIV, especially H SeIV, has a pro-oxidant effect on the CLA isomers in the spleen. The pro-oxidative properties of sodium selenite are known from in vitro and in vivo experiments (Spallholz, 1997; Terada et al., 1999; Boldižárová et al., 2005) . Consequently, the combined addition of CLAmix and H SeY to the diet showed a high but not significant increase of the concentration of c9t11CLA in the spleen (+27%) and blood plasma (+21%). This diet particularly efficiently increased the total concentration of all assayed CLA isomers (+27%) in plasma. Moreover, the diet with the combined addition of CLAmix and Se as SeIV or SeY stimulated the accumulation of t10c12CLA and c11t13CLA in plasma compared with the diet enriched in only CLAmix.
Our results indicate that the ratio of the concentrations of c9t11CLA to t10c12CLA in the spleen of rats fed the diet enriched with the CLAmix was lower compared with the ratio of these isomers in the CLA isomer mixture added to the diets (i.e. 0.746 vs 0.988; see Table 1 ). Our present results are in agreement with our previous study (Niedźwiedzka et al., 2006) , in which t10c12CLA and t10t12CLA were also less efficiently metabolized than c9t11CLA in the spleen of rats fed a diet with 1 or 2% CLA isomer mixture. Thus, our current and previous studies clearly document that c9t11CLA is more efficiently metabolized than t10c12CLA or t10t12CLA in the spleen. Our findings are not in agreement with those of Alasnier et al. (2002) and our previous studies (Niedźwiedzka et al., 2006; Korniluk et al., 2007; Czauderna et al., 2007a Czauderna et al., , 2009 Czauderna et al., , 2010a showing that the t10c12 and t10t11CLA isomers were also more efficiently metabolized in other organs and tissues (e.g., the liver, pancreas, brain, kidneys, heart, adipose tissues, blood plasma and muscles) than the c9t11 isomer. Our results documented that the spleen is a unique internal organ possessing a more efficient c9t11CLA metabolism than other internal organs, adipose tissue, blood plasma, and muscles. On the other hand, in the current study, it was found that the metabolic efficiency of isomer t10c12 in plasma was higher than that of c9t11CLA, which is in agreement with the results of Alasnier et al. (2002) and our studies on the liver, heart, muscle, kidney, pancreas and brain of rats (Niedźwiedzka et al., 2006; Korniluk et al., 2007; Czauderna et al., 2010a,b) . Interestingly, our current study documented that the c9t11CLA/t10c12CLA ratio in the spleen and plasma is affected by the addition of SeIV or SeY to the diet containing CLAmix. As can be seen from the results summarized in Table 1 , the addition of L SeIV to the diet containing CLAmix increased the metabolic efficiency of t10c12CLA compared with the diet enriched in only CLAmix. On the other hand, the addition of the higher amount of SeY the diet with CLAmix stimulated the accumulation of c9t11CLA in the spleen and plasma. Supplementing H SeIV or L SeY diets with CLAmix significantly reduced the concentration of c9t11CLA and t10c12CLA in the spleen, although isomer c9t11 is metabolized more efficiently than t10c12CLA. In plasma, these additives in the diet with CLAmix slightly reduced the efficiency of isomer t10c12 metabolism, while somewhat increasing the rate of c9t11CLA metabolism, although the ratio of c9t11CLA to t10c12CLA was lower than in rats given the diet with CLAmix.
The effect the experimental diets on the concentration of saturated, monoand polyunsaturated fatty acids in the spleen and blood plasma of rats. The diet enriched in CLAmix, regardless of the presence of SeIV or SeY, significantly decreased the concentration of c9C18:1, c11C18:1 as well as the total concentration of all assayed monounsaturated fatty acids (MUFA) in the spleen compared with the control group or rats fed the diet containing L SeIV, H SeIV, or L SeY in particular (Table 2 ). This effect could be related to reduction of Δ9-desaturation capacity in the spleen of rats fed the diet containing CLAmix, regardless of the presence of SeIV or SeY. In contrast, dietary SeIV, irrespective of its concentration in the diet, increased the Δ9-desaturation index in the spleen and plasma, while dietary SeY, especially, H SeY decreased the value of this index. The present results support our previous studies on rats fed a diet containing 1.2 ppm Se as selenized yeast (SeY) with or without CLA isomer mixture Niedźwiedzka et al., 2007) , which also documented that the diet with 1.2 ppm as SeY decreased the Δ9-desaturation index in the spleen of rats and blood plasma.
Unexpectedly, the diet containing CLAmix stimulated the accumulation of t11C18:1 in the spleen and plasma compared with the control group and rats fed the diet with SeIV or SeY (Table 2) . Moreover, the addition of L SeIV or H SeY to the diet with CLAmix resulted in more efficient accumulation of t11C18:1 in the spleen and plasma than the diet containing only CLAmix. Considering the above, we suggest that the presence of t11C18:1 in the spleen and plasma documents coprophagia of rats, as well as that some CLA isomers added to the rat diet are precursors of accumulated t11C18:1.
The splenic concentration of myristic acid (C14:1), as well as the total concentration of all assayed saturated fatty acids (SFA) having a detrimental effect on animal and human health, decreased with CLAmix and H SeY treatments. Similarly, the addition of SeIV or SeY to the diet enriched in CLAmix decreased the concentration of these fatty acids in the spleen. Unexpectedly, supplementation of SeIV to the diet increased the concentration of C14:0 and SFA in the spleen and plasma. In addition, H SeY treatment and supplementation of CLAmix and Se (as SeIV or SeY) increased the concentration of these fatty acids in plasma. Changes in saturated fatty acid concentrations in the spleen and plasma are consistent with changes in the atherogenic and thrombogenic properties of the spleen and blood plasma. Indeed, the addition of CLAmix or H SeY to the diet decreased the concentrations of atherogenic (A-SFA) and thrombogenic (T-SFA) saturated fatty acid in the spleen, and increased them in plasma (Table 3) . Supplementing CLAmix and Se (as SeIV or SeY) to diets decreased the levels of these fatty acids in the spleen, while increasing them in plasma. Additionally, the diet containing the higher level of SeIV stimulated the accumulation of A-SFA and T-SFA in the spleen and plasma.
An inverse relationship between concentrations of A-SFA and T-SFA in the spleen and blood plasma and values of atherogenic (A index ) and thrombogenic (T index ) indexes in these tissues was found (Table 3 ). In fact, the addition of (Table 4 ). In contrast, more efficient accumulation of A-SFA and T-SFA in plasma is responsible for the increase in the A index and T index values. Indeed, changes in the concentrations of PUFA, PUFAn-3, and PUFAn-6/PUFAn-3 ratio in plasma (Table 4) are usually small and not responsible for increasing A index and T index values (Ulbricht and Southgate, 1991) .
Rats fed the diet enriched in CLAmix with or without Se (as SeIV or SeY) showed decreased concentrations of linoleic (LA), α-linolenic (αLNA), arachidonic (AA), docosapentaenoic (DPA) and docosahexanoic (DHA) acids as well as the total concentration of the assayed PUFA in the spleen compared with the control rats (Tables 3 and 4) . Additionally, these diets reduced spleen concentrations of PUFAn-3 and long-chain PUFAn-3 (LPUFAn-3) and LPUFAn-6, while increasing the PUFAn-6/PUFAn-3 ratio with the exception of the diet containing only CLAmix. In contrast, the diet enriched in L SeY, and especially H SeIV, considerably increased spleen concentrations of the polyunsaturated fatty acids mentioned above and decreased the PUFAn-6/PUFAn-3 ratio. Surprisingly, the addition of the higher amount of SeY to the diet decreased the spleen concentrations of these fatty acids and increased the PUFAn-6/PUFAn-3 ratio. It appears that the highly bioavailable chemical form of dietary Se at the higher dose (i.e. 0.5 ppm Se as SeY) exhibited some pro-oxidative. It has been suggested that larger doses of dietary selenized yeast may lead to higher continuous release of selenomethionine from body deposits into the free amino acid pool with a subsequently higher production of H 2 Se, which has pro-oxidative properties (Boldižárová et al., 2005) . PUFA mg/g n-6/n-3
LPUFA μg/g n-3
PUFA μg/g n-6/n-3 In contrast, the diet containing CLAmix or H SeY increased the concentration of the above-mentioned individual polyunsaturated fatty acids as well as PUFA, LPUFAn-3, LPUFAn-6, and PUFAn-3 in plasma compared with the control group. Other experimental diets showed a small and inconsistent influence on the concentrations of these fatty acids in plasma. Supplementing L SeY or H SeY alone to diets or to the diet containing CLAmix decreased PUFAn-6/PUFAn-3 ratios in plasma.
The rat diet enriched in 1.5% CLAmix with or without Se (as SeIV or SeY) significantly increased Δ6-desaturase index values in the spleen and plasma (Table  5) . Additionally, rats in the SeIV or SeY treatments presented a higher value of this index in plasma than the control group. Values of the Δ4-, Δ5-desaturase indexes and the elongase index were slightly higher in the spleen of rats fed the diet enriched in CLAmix; the addition of SeIV or SeY to the diet with CLAmix increased the values of these indexes in the spleen in comparison with the diet containing only CLAmix. Similarly, values of the plasma elongase index were higher rats fed the diets enriched in both CLAmix and Se (as SeIV or SeY) than in the control group or rats in the SeIV, SeY, or CLAmix treatments.
Unexpectedly, the diet enriched in CLAmix resulted in a decrease in the ratios of PUFA/SFA, MUFA/SFA, PUFA/ΣFA (Table 5 ) and UFA/ΣFA (Table 1) in the spleen and plasma. The addition of SeIV or SeY to the diet containing CLAmix usually slightly decreased the values of these ratios in the spleen and plasma in comparison with rats fed the diet with CLAmix. Similarly, the H SeY treatment decreased the values of these ratios in both examined tissues. Considering the above, it appears that dietary CLAmix and/or Se (as SeIV or SeY) resulted in a different composition pattern of SFA, MUFA and PUFA in the spleen and blood plasma.
CONCLUSIONS
This study describes changes in fatty acid profiles in the spleen and plasma as a result of the addition of 1.5% CLAmix and various amounts of sodium selenite (SeIV), selenized yeast (SeY) to the rat diet. The results document that the CLAmix treatment more significantly stimulated the metabolic, especially catabolic, processes of poly-(PUFA) and monounsaturated fatty acids (MUFA) in the spleen than saturated fatty acids (SFA). The efficiency of PUFA and MUFA metabolism in the spleen was increased by dietary supplementation of SeIV or SeY to the diet containing CLAmix. These final conclusions are well confirmed by changes in the values of the elongase and Δ4-, Δ5-, and Δ6-desaturase indexes and the PUFA/SFA and MUFA/SFA ratios in the spleen. On the other hand, the diet containing CLAmix, irrespective of the presence of SeIV or SeY, stimulated the accumulation of MUFA, PUFA, and SFA in blood plasma.
The diet enriched CLAmix and the higher amount of SeY most efficiently stimulated accumulation of CLA isomers, especially health-promoting c9t11CLA in the spleen and plasma. We demonstrated that c9t11CLA in the rat spleen is more efficiently metabolized than t10c12CLA, while in other internal organs, muscles, and adipose tissues, t10c12CLA is metabolized faster than the c9t11 isomer.
Further research is needed to determine if dietary selenium compounds and individual CLA isomers also induce changes in fatty acid profiles and elongase and desaturase indexes in the spleen and blood plasma of rats.
